scorpion
- 13 Aug 2003 13:54
Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.
daves dazzlers
- 29 Oct 2004 14:24
- 1139 of 2372
Bang on,,dil rushy 25/1 looking good now.
Dil
- 29 Oct 2004 14:25
- 1140 of 2372
I aint in
daves dazzlers
- 29 Oct 2004 14:28
- 1141 of 2372
dil,football 2004/2005,traders,have a look.
bradley007
- 29 Oct 2004 15:31
- 1142 of 2372
Finally holding at 108.....phew...
emailpat
- 30 Oct 2004 19:43
- 1143 of 2372
bradley007-Where to from here? possible news Tues!
DSTOREY9916
- 30 Oct 2004 21:56
- 1144 of 2372
Am I correct in thinking that we can expect announcement in regards recent court case, 02 Nov?
Ramrod
- 30 Oct 2004 22:42
- 1145 of 2372
Dstorey
The next stage is indeed 2.11.04 - may not be finalised on the day though .
DSTOREY9916
- 30 Oct 2004 23:04
- 1146 of 2372
Ramrod, cheers...D
Janus
- 31 Oct 2004 08:01
- 1147 of 2372
Nasdaq listings in America are not all they are promised to be, at least in the short term.
I learned this nearly a decade ago following Mid-States, a shell company re-named after a reverse takeover by a US car parts business. Its shares soared from penny status to 125p on excitement about its aim to list jointly on Nasdaq. The business was reporting sound profits and looked materially undervalued relative to US quoted rivals. But as soon as the listing became effective Mid-States shares dived. Having sold the car parts business, it is once again a shell.
As hopes gathered over a Nasdaq listing for BioProgress (the Aim-quoted developer of non-gelatin pills and other products) I wondered if there might be a similar effect. Certainly, this was a factor cautioning me against switching into BioProgress as its shares rose from about 100p to 130p.
After the Nasdaq listing became effective the shares promptly shed these gains. It looks like a trading rule of thumb to buy shares on the expectation of a Nasdaq listing and sell on the event - or even go short or establish a spread bet down.
A key hope with US listings is that they will attract a new range of shareholders. With a company such as BioProgress, there are sound long-term reasons for developing its profile in the US. Plenty of people here were buying its shares recently on the basis of its overall potential, not just the Nasdaq listing. But all the same, it does not necessarily follow that such a listing would bring in new buyers.
Traders should note the classic rise and fall, which has good odds of repeating itself in other shares. Long-term investors can certainly ignore all this "noise trading".
http://tinyurl.com/5r66u
bradley007
- 01 Nov 2004 10:50
- 1148 of 2372
Hi All
Forgive me, but as BPRG is a bi boring today, check out
CHR. Just gone through a consolidation, a few buyers this morning moved the price 10%... Like the sector.. just about to buy a few grand as
a punt...
We expecting any news on the Stanelco situation today?
ptholden
- 01 Nov 2004 10:59
- 1149 of 2372
Believe the case will be heard tomorrow.
Janus
- 01 Nov 2004 12:14
- 1150 of 2372
Sorry to be pedantic. The case has already been won by BPRG its the amount of damages to be decided tommorrow.
bradley007
- 01 Nov 2004 13:20
- 1151 of 2372
Thanks for the clarification.. taxation I believe? Anyone pick up CHR,
just looking at a neat 650 profit...
johngtudor
- 01 Nov 2004 16:56
- 1152 of 2372
bradley007: Looked at CHR after your earlier tip, IYO is there more upside and why?
Re tomorrow, having made some inquiries, I suspect that the only agreement tomorrow will be the costs payable by SEO immediately. There will be another amount claimed and disputed that will go to an independent court appointed accountant to verify. What happens next is key. Does InGel have sufficient funds or backers to meet the demands made by BPRG? In these situations the claiming company (BPRG) will want to know how much revenue has been generated by InGel using the derived patents. The cleanest outcome could well be BPRG taking all over InGel! Naturally the defending company will fight this tooth and nail, so we can expect a confused and muddied outcome, but if the Judge has reviewed the case already we might be surprised.
Any comments welcome! John
Janus
- 01 Nov 2004 17:38
- 1153 of 2372
Tend to agree. Pure speculation but I bet BPRG will go for costs around the 500k level.
For info if anybody wants to go its court 52 and is in open court. I believe there are 50 odd spaces.
johngtudor
- 01 Nov 2004 17:49
- 1154 of 2372
If anybody reading this BB does attend please file a report immediately to us on the outcome!!! Thanks in advance!
AdieH
- 02 Nov 2004 08:11
- 1155 of 2372
Yes please keep us shareholders updated whoever gets to go could be interesting times ahead...
bradley007
- 02 Nov 2004 11:17
- 1156 of 2372
John, thanks for that, waiting with baited breath...
To be honest CHR was a punt, it looked like the price after consolidation was a
bit out of kilter, so I bought for the day and sold this morning at 175, its off since. There are only 6m shares in issue so any buying will move the price... its on my watch list..
AdieH
- 02 Nov 2004 13:33
- 1157 of 2372
Anyone got any news, BPRG down SEO holding... Should we get a summary at the end of play today?
emailpat
- 02 Nov 2004 13:38
- 1158 of 2372
Still going on-from what I can gather seo trying to say patent invalid-clutching at straws imo.